CYTOKINETICS INC — Director's Dealing 2022

Sep 12, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2022-09-12

Reporting Person: HENDERSON JOHN T (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-12	Common Stock	M	7250	$4.02	Acquired	31299	Direct
2022-09-12	Common Stock	S	7250	$54.942	Disposed	24049	Direct
2022-09-12	Common Stock	M	7250	$4.02	Acquired	31299	Direct
2022-09-12	Common Stock	S	7250	$54.952	Disposed	24049	Direct
2022-09-12	Common Stock	M	7259	$4.02	Acquired	31308	Direct
2022-09-12	Common Stock	S	7259	$54.941	Disposed	24049	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-09-12	Non-Qualified Stock Option (Right to Buy)	$4.02	M	7250	Disposed	2023-01-02	Common Stock (7250)	Direct
2022-09-12	Non-Qualified Stock Option (Right to Buy)	$4.02	M	7250	Disposed	2023-01-02	Common Stock (7250)	Direct
2022-09-12	Non-Qualified Stock Option (Right to Buy)	$4.02	M	7259	Disposed	2023-01-02	Common Stock (7259)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	83	Indirect

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 11, 2022.